All stocks / GPLB
Green Planet Bio Engineering Co. Ltd. GPLB
Green Planet Bio Engineering (GPLB): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- GREEN PLANET BIOENGINEERING CO LTD
- Market tier
- OTC Pink Limited
- Trading status
- Active
- Last trade
- Nov 16
The financial report, and what it means
Annual figures to 2025-12-31- Net loss
- ($35,842)
It spends more than it earns
Under strainThe company lost $35,842 in the year. It reported no sales.
- Cash and cash equivalents
- $0
- Net cash used in operating activities
- ($36,544)
The cash could run out soon
Under strainIt had $0 in the bank and used about $3,045 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.
What this adds up to
2 of 2 checks show strain. It spends more than it earns. The cash could run out soon. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 20,006,402 shares as of 2026-11-13: 20,006,402 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about GPLB
Does GPLB file reports with the SEC?
Yes. Green Planet Bio Engineering files with the SEC under company number 0001392449. The most recent filing we hold is a 10-Q dated 2026-11-13.
Source recordHow many GPLB shares are outstanding?
20,006,402 shares as of 2026-11-13, as reported to the SEC.
Source recordHas GPLB filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Is Green Planet Bio Engineering making money?
The company lost $35,842 in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record